Insmed Delivers ‘Rare Disappointment’ as Brinsupri Flops in Mid-Stage Rhinosinusitis StudyBy Leonardo Arias / 19/12/2025 Insmed pointed to a strong placebo response as the reason for the trial’s failure.
